- Home
- XGN vs BCG Comparison
XGN vs BCG Comparison
Compare XGN & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XGN | BCG |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.9M | 29.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | XGN | BCG |
|---|---|---|
| Price | $7.11 | $2.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $13.67 | N/A |
| AVG Volume (30 Days) | 307.0K | ★ 2.0M |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $63,599,000.00 | ★ $178,203,000.00 |
| Revenue This Year | $22.15 | N/A |
| Revenue Next Year | $15.26 | N/A |
| P/E Ratio | ★ N/A | $57.50 |
| Revenue Growth | ★ 14.08 | 10.19 |
| 52 Week Low | $2.67 | $1.36 |
| 52 Week High | $12.23 | $6.00 |
Technical Indicators
Market Signals| Indicator | XGN | BCG |
|---|---|---|
| Relative Strength Index (RSI) | 30.11 | 47.53 |
| Support Level | $7.01 | $2.33 |
| Resistance Level | $7.33 | $3.07 |
| Average True Range (ATR) | 0.32 | 0.38 |
| MACD | 0.07 | -0.04 |
| Stochastic Oscillator | 18.09 | 0.00 |
Price Performance
Historical ComparisonAbout XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.